Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 29;14(8):e0221643.
doi: 10.1371/journal.pone.0221643. eCollection 2019.

Association between Helicobacter pylori infection and arterial stiffness: Results from a large cross-sectional study

Affiliations

Association between Helicobacter pylori infection and arterial stiffness: Results from a large cross-sectional study

Ji Min Choi et al. PLoS One. .

Abstract

Background: Chronic systemic inflammation is an important causative factor in the pathogenesis of atherosclerosis. However, the effect of chronic Helicobacter pylori (Hp) infection on arterial stiffness, a predictor of cardiovascular events, remains unclear. We evaluated the association between Hp infection and arterial stiffness in asymptomatic healthy individuals.

Methods: Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI). We included subjects who underwent CAVI and anti-Hp IgG antibody evaluations, simultaneously, between March 2013 and July 2017. Demographic characteristics and metabolic and cardiovascular parameters were compared with respect to anti-Hp IgG antibody status. Multivariable logistic regression analyses were performed to determine the effect of Hp-seropositivity and conventional cardiovascular risk factors on arterial stiffness.

Results: Of 2,251 subjects, 1,326 (58.9%) were included in the Hp-seropositive group. Median age (P < 0.001) and systolic blood pressure (P = 0.027) were significantly higher in the Hp-seropositive than in the Hp-seronegative group. Levels of LDL-cholesterol were significantly higher in the Hp-seropositive than in the Hp-seronegative group (P = 0.016). Other serum metabolic parameters were not significantly different between the two groups. The median CAVI value and the proportion of subjects with a CAVI ≥ 8 were significantly higher in the Hp-seropositive than in the Hp-seronegative group (both P < 0.001). On multivariable logistic regression analyses, Hp-seropositivity, age, body mass index, waist circumference, smoking, hypertension, diabetes mellitus, and dyslipidemia were significantly associated with high CAVI values. In the subgroup analysis conducted according to age group, a tendency towards an increased association between Hp-seropositivity and CAVI was observed with increasing age, even though the difference did not reach the statistical significance.

Conclusions: Hp-seropositivity was significantly associated with arterial stiffness. Hp infection may contribute to the development of cardiovascular diseases.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study population.
CAVI, cardio-ankle vascular index; H. pylori, Helicobacter pylori; n, number; IHD, ischemic heart disease; PAD, peripheral artery disease.
Fig 2
Fig 2. Subgroup analysis of the effect of Hp-seropositivity on CAVI levels by age group.
When multivariable analysis was performed with variables affecting CAVI, the effect of Hp-seropositivity on CAVI levels increased with age. However, we did not find any significant interaction between age and Hp infection on arterial stiffness through a test of interaction. Hp, Helicobacter pylori; CAVI, cardio-ankle vascular index; n, number; OR, odds ratio; CI, confidence interval.

References

    1. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19 Suppl 1:1–5. 10.1111/hel.12165 - DOI - PubMed
    1. Konturek SJ, Konturek PC, Konturek JW, Plonka M, Czesnikiewicz-Guzik M, Brzozowski T, et al. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation. J Physiol Pharmacol. 2006;57 Suppl 3:29–50. - PubMed
    1. Vainio H, Heseltine E, Wilbourn J. Priorities for Future IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Environ Health Perspect. 1994;102:590–591. 10.1289/ehp.94102590 - DOI - PMC - PubMed
    1. Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and extragastric diseases. Helicobacter. 2014;19 Suppl 1:52–58. 10.1111/hel.12159 - DOI - PubMed
    1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126. 10.1056/NEJM199901143400207 - DOI - PubMed

MeSH terms